Inventor · disambiguated record
Volker Sandig
Also filed as: SANDIG VOLKER
13 granted patents·12 pending applications·123 citations·filing 1996–2022
89Inventor score
Top patents by PatentIndex Score
25 records- 0190US8642292B2Process for producing molecules containing specialized glycan structuresSANDIG VOLKER·Filed 2010·Granted Feb 4, 2014·64 cites·24 claims
- 0283US7132277B1Helper dependent vector system for gene therapyMERCK & CO INC·Filed 2000·Granted Nov 7, 2006·16 cites·15 claims
- 0380US8940534B2Immortalized avian cell lines for virus productionSANDIG VOLKER·Filed 2004·Granted Jan 27, 2015·9 cites·17 claims
- 0470US9732325B2MVA virus and uses thereofPROBIOGEN AG·Filed 2012·Granted Aug 15, 2017·1 cites·17 claims
- 0560US2025066427A1Therapeutic papilloma virus vaccinesSIRION BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 0656US5895759AVector for gene transfer in liver cellsMAX PLANCK GESELLSCHAFT·Filed 1996·Granted Apr 20, 1999·18 cites·3 claims
- 0755US6025195ALiver-specific adenovirus expression vectorMAX PLANCK GESELLSCHAFT·Filed 1996·Granted Feb 15, 2000·15 cites·10 claims
- 0853US2024299476A1Use of a birnavirus alone or in combination therapy for the treatment of cancerPROBIOGEN AG·Filed 2021·Application pending·0 cites
- 0952US8815540B2Productivity augmenting protein factor, novel cell lines and uses thereofSANDIG VOLKER·Filed 2008·Granted Aug 26, 2014·0 cites·5 claims
- 1051US11999975B2Method for purifying an enveloped virusPROBIOGEN AG·Filed 2019·Granted Jun 4, 2024·0 cites·7 claims
- 1151US2011229969A1Cell Line for Propagation of Highly Attenuated AlphaVirusesSANDIG VOLKER·Filed 2009·Application pending·0 cites
- 1250US8679839B2Cell line from rousettus as host cell for pathogen amplificationJORDAN INGO·Filed 2009·Granted Mar 25, 2014·0 cites·17 claims
- 1350US2012288916A1Immortalized avian cell lines for virus productionSANDIG VOLKER·Filed 2012·Application pending·0 cites
- 1449US2004106194A1Methods for propagating adenovirus and virus produced therebyFiled 2003·Application pending·0 cites
- 1548US2023257778A1Hyperactive transposons and transposasesPROBIOGEN AG·Filed 2020·Application pending·0 cites
- 1646US2024024390A1Use of a birnavirus alone or in combimation therapy for the treatment of a disease caused by a nidovirusPROBIOGEN AG·Filed 2020·Application pending·0 cites
- 1744US2005054105A1Adenoviral vector systemFiled 2002·Application pending·0 cites
- 1844US2006148085A1High yield heterologous expression cell lines for expression of gene products with human glycosylation patternSANDIG VOLKER·Filed 2003·Application pending·0 cites
- 1944US2004265821A1Rna amplication system using plant components in animal cellsSANDIG VOLKER·Filed 2002·Application pending·0 cites
- 2042US9163089B2Enhancement of protein production yield mediated by a fast shuttling CDC42 GTPaseSANDIG VOLKER·Filed 2012·Granted Oct 20, 2015·0 cites·17 claims
- 2141US11104884B2Vaccinia virus vectors related to MVA with extensive genomic symmetriesPROBIOGEN AG·Filed 2017·Granted Aug 31, 2021·0 cites·15 claims
- 2239US2022090142A1Transposase with enhanced insertion site selection propertiesPROBIOGEN AG·Filed 2019·Application pending·0 cites
- 2337US11060069B2Porcine cell line for virus productionPROBIOGEN AG·Filed 2016·Granted Jul 13, 2021·0 cites·17 claims
- 2434US2008057584A1Intervention In The Energy Metabolism Of Eukaryote Cells For The Purposes Of Selection And Increased ExpressionSANDIG VOLKER·Filed 2005·Application pending·0 cites
- 2532US9765158B2Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extendersVON HORSTEN HANS HENNING·Filed 2012·Granted Sep 19, 2017·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →